Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis: bench to bedside, have we learned anything?

Seung Uk Lee1, Joanna J Wykrzykowska, Roger J Laham

  • 1Cardiovascular Division, BIDMC/Harvard Medical School, Boston, Massachusetts 02215, USA.

Toxicologic Pathology
|March 2, 2006
PubMed
Summary

Angiogenesis therapies show promise for ischemic cardiomyopathy but face challenges. A structured research model is proposed to overcome limitations and advance treatment for end-stage cardiac ischemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Procedural Strategies for Optimal Transcatheter Aortic Valve Replacement: An International Position Statement.

JACC. Cardiovascular interventions·2026
Same author

Left ventricular changes in moderate aortic stenosis in women compared to men.

European heart journal. Imaging methods and practice·2026
Same author

Mitral Valve Leaflet Modification: A Working Group Position Statement on Best Practices and Step-by-Step Guide.

JACC. Cardiovascular interventions·2026
Same author

UNICORN During Transcatheter Aortic Valve Replacement in Native and Bioprosthetic Aortic Valves: A Multicenter Study.

JACC. Cardiovascular interventions·2026
Same author

Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial.

Circulation·2026
Same author

Aortic Valve Leaflet Modification: A Working Group Position Statement on Best Practices and Step-by-Step Guide.

JACC. Cardiovascular interventions·2026

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Molecular Biology

Background:

  • End-stage ischemic cardiomyopathy is a growing concern with limited treatment options.
  • Early angiogenesis therapy trials demonstrated potential, but later trials failed to confirm benefits of single growth factors.
  • Challenges include complexity of angiogenesis, inadequate animal models for human ischemic myocardium, and controlling for placebo effects.

Purpose of the Study:

  • To review the challenges in angiogenesis research and treatment strategy development for ischemic cardiomyopathy.
  • To propose a structured model for future investigations into angiogenic therapies.

Main Methods:

  • Review of existing literature on angiogenesis therapy for ischemic cardiomyopathy.
  • Analysis of limitations in pre-clinical and clinical trial methodologies.

Related Experiment Videos

  • Development of a proposed structured research model.

    • Main Results:

    • Single growth factor angiogenesis treatments have not translated successfully to larger clinical trials.
    • Significant hurdles exist in modeling human ischemic myocardium and controlling for placebo effects in clinical studies.
    • Current outcomes assessment methods are inadequate for establishing efficacy.

    Conclusions:

    • Overcoming the complexities of angiogenesis research requires a more rigorous and structured approach.
    • The proposed model offers a framework for future investigations to improve the success of angiogenic therapies.
    • A regimented approach is essential for developing effective angiogenesis treatments for refractory cardiac ischemia.